GLA
AXSM icon

Great Lakes Advisors’s Axsome Therapeutics AXSM Stock Holding History

Great Lakes Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Sell
6,730
-35
-0.5% -$6.04K 0.01% 497
2025
Q4 		$1.24M Buy
6,765
+89
+1% +$12.4K 0.01% 494
2025
Q3 		$811K Buy
6,676
+306
+5% +$34.5K 0.01% 547
2025
Q2 		$665K Sell
6,370
-823
-11% -$87.1K 0.01% 575
2025
Q1 		$839K Sell
7,193
-6,315
-47% -$719K 0.01% 529
2024
Q4 		$1.14M Sell
13,508
-3,220
-19% -$296K 0.01% 563
2024
Q3 		$1.5M Buy
16,728
+4,587
+38% +$400K 0.01% 526
2024
Q2 		$977K Buy
+12,141
New +$899K 0.01% 580

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Great Lakes Advisors's AXSM Position: Q1 2026 in Review

Great Lakes Advisors reduced its Axsome Therapeutics (AXSM) stake by 0.52% in Q1 2026, selling an estimated $6.04K and leaving 6,730 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #497.

Great Lakes Advisors first reported a position in AXSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.5M in Q3 2024. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Great Lakes Advisors held 6,730 shares of Axsome Therapeutics worth $1.14M as of Q1 2026.
  • Great Lakes Advisors sold 35 Axsome Therapeutics shares in Q1 2026, an estimated $6.04K.
  • Axsome Therapeutics made up 0.01% of Great Lakes Advisors's portfolio in Q1 2026, its #497 holding.
  • Great Lakes Advisors first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Great Lakes Advisors's Axsome Therapeutics position peaked at $1.5M in Q3 2024.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Great Lakes Advisors's 13F filing for Q1 2026, filed 12 May 2026.